gastroesophageal reflux-associated chronic cough
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Chronic cough group Patients with persistent cough for 8 weeks or longer and concomitantly having GERD symptom. 2) Control group Patients with GERD but without cough symptom
Exclusion criteria
Exclusion criteria: 1)patients recieved oral or systemic steroid within one month. 2)patients recieved proton-pomp inhibitor and histamine H2 receptor antagonist within one month. 3)patients having angiotensin converting enzyme inhibitor, anti-leukotriene receptor antagonist and histamine H1 receptor antagonist. 4)patients who are pregnant or possibly pregnant. 5)Patients who are inappropriate to enter this study judged by the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression level of TRPV1, TRPV4 and ENAC in esophageal mucosa | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Expression level of SP and CGRP in esophageal mucosa. 2)relationship between expression level of TRPV1, TRPV4, ENAC, SP and CGRP and clinical indicators. | — |
Countries
Japan
Contacts
Graduate School of Medical Sciences, Nagoya City University Respiratory Medicine, Allergy and Clinical Immunology